❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Imaging facilities
  • Institute seminars
  • Vacant positions
  • News archive
  • Tweets
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Bruland ØS, Larsen RH, Baum RP, Juzeniene A (2023)
Editorial: Targeted alpha particle therapy in oncology
Front Med (Lausanne), 10, 1165747
DOI 10.3389/fmed.2023.1165747, PubMed 36960341

Pettersen S, Øy GF, Egeland EV, Juell S, Engebråten O, Mælandsmo GM, Prasmickaite L (2023)
Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
Front Oncol, 13, 1040665
DOI 10.3389/fonc.2023.1040665, PubMed 36910663

Chauhan SK, Casado RB, Landsverk OJB, Johannessen H, Phung D, Nilsen HR, Sætre F, Jahnsen J, Horneland R, Yaqub S, Aandahl EM, Lundin KEA, Bækkevold ES, Jahnsen FL (2023)
The human small intestine contains two functionally distinct regulatory T-cell subsets
J Allergy Clin Immunol (in press)
DOI 10.1016/j.jaci.2023.02.030, PubMed 36893861

More selected publications

Most recent publications

Zhang D, Harris HM, Chen J, Judy J, James G, Kelly A, McIntosh J, Tenn-McClellan A, Ambing E, Tan YS, Lu H, Gajewski S, Clifton MC, Yung S, Robbins DW, Pirooznia M, Skånland SS, Gaglione E, Mhibik M, Underbayev C, Ahn IE, Sun C, Herman SEM, Noviski M, Wiestner A (2023)
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts
Blood, 141 (13), 1584-1596
DOI 10.1182/blood.2022016934, PubMed 36375120

Haroun-Izquierdo A, Lanuza PM, Pfefferle A, Netskar H, Ask EH, Törlén J, Björklund A, Sohlberg E, Malmberg KJ (2023)
Effect of mTOR inhibition with sirolimus on natural killer cell reconstitution in allogeneic stem cell transplantation
Transplant Cell Ther (in press)
DOI 10.1016/j.jtct.2023.03.023, PubMed 36966873

Ito I, Yousef AM, Dickson PN, Naini ZA, White MG, Fleten KG, Flatmark K, Fournier KF, Fowlkes NW, Shen JP (2023)
Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma
bioRxiv
DOI 10.1101/2023.02.01.526672, PubMed 36993681

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy

Accessibility statement (in Norwegian)